ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme

Mu, Long; Han, Zhibin; Yu, Shengkun; Wang, Aowen; Chen, Dongjiang; Kong, Sijia; Gu, Yifei; Xu, Lin; Liu, Axiang; Sun, Ruohan*; Long, Yu*北京大学; 哈尔滨医科大学; 1; y
Frontiers in Immunology2022-12-21DOI: 10.3389/fimmu.2022.842524
2被引3阅读
引用收藏
分享

摘要

BackgroundAnkyrin repeat and SOCS Box containing 3 (ASB3) is an E3 ubiquitin ligase. It has been reported to regulate the progression of some cancers, but no systematic pan-cancer analysis has been conducted to explore its function in prognosis and immune microenvironment. MethodIn this study, mRNA expression data were downloaded from TCGA and GTEx database. Next generation sequencing data from 14 glioblastoma multiforme (GBM) samples by neurosurgical resection were used as validation dataset. Multiple bioinformatics methods (ssGSEA, Kaplan-Meier, Cox regression analysis, GSEA and online tools) were applied to explore ASB3 expression, gene activity, prognosis of patients in various cancers, and its correlation with clinical information, immune microenvironment and pertinent signal pathways in GBM. The biological function of ASB3 in tumor-infiltrating lymphocytes (TILs) was verified using an animal model. ResultsWe found that ASB3 was aberrant expressed in a variety of tumors, especially in GBM, and significantly correlated with the prognosis of cancer patients. The level of ASB3 was related to the TMB, MSI and immune cell infiltration in some cancer types. ASB3 had a negative association with immune infiltration and TME, including regulatory T cells (Tregs), cancer-associated fibroblasts, immunosuppressors and related signaling pathways in GBM. ASB3 overexpression reduced the proportion of Tregs in TILs. GSEA and PPI analysis also showed negative correlation between ASB3 expression and oncogenetic signaling pathways in GBM. ConclusionA comprehensive pan-cancer analysis of ASB3 showed its potential function as a biomarker of cancer prognosis and effective prediction of immunotherapy response. This study not only enriches the understanding of the biological function of ASB3 in pan-cancer, especially in GBM immunity, but also provides a new reference for the personalized immunotherapy of GBM.

学科与关键词

关键词
glioblastoma multiformeE3 ubiquitin ligasesASB3tumor microenvironmentTregs
相关
加载中…
  • The E3 ubiquitin ligase RBCK1: Implications in the tumor immune microenvironment and antiangiogenic therapy of glioma
    Guo, Jing; Sun, Donglin; Zhang, Junwei; Guo, Jie; Wu, Zhenpeng; Chen, Yongzhen; Xu, Yujie; Zhou, Desheng; Cui, Yachao; Mo, Qi; Li, Yingchang; Zhao, Ting*; You, Qiang*Computational and Structural Biotechnology Journal, 2023, 21: 5212-5227.
  • Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target
    Huang, Guang-zhao; Chen, Ze-qun; Wu, Juan; Shao, Ting-ru; Zou, Chen; Ai, Yi-long*; Lv, Xiao-zhi*Journal of Immunology Research, 2021, 2021: 9250207.被引 6
  • β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion
    Luo, Yinghao; Wang, Kan; Zhan, Lu; Zeng, Fanyue; Zheng, Jie; Chen, Sijing; Duan, Xingbang; Ju, Donghui*Frontiers in Oncology, 2023, 13: 1214413.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-12-21
卷期
第 13 卷
页码
842524
DOI
10.3389/fimmu.2022.842524
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • M

    Mu, Long (第一作者)

    1 · harbin med univ

  • H

    Han, Zhibin

    1 · harbin med univ

查看全部 11 位作者收起作者
  • Y

    Yu, Shengkun

    1 · harbin med univ

  • W

    Wang, Aowen

    1 · harbin med univ

  • C

    Chen, Dongjiang

  • K

    Kong, Sijia

    peking univ shenzhen

  • G

    Gu, Yifei

    1 · harbin med univ

  • X

    Xu, Lin

    1 · harbin med univ

  • L

    Liu, Axiang

    1 · harbin med univ

  • S

    Sun, Ruohan (通讯)

    1 · harbin med univ

  • L

    Long, Yu (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417